Advertisement
Screener

PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) Executive Pay versus Performance: Pay versus Performance

PROTHENA CORPORATION PUBLIC LIMITED COMPANY Pay versus Performance

The Pay versus Performance table from each proxy statement (Item 402(v)), as tagged in its XBRL, newest proxy first. Each proxy's own figures are kept, so a year restated in a later proxy appears once per proxy. PEO is the principal executive officer; NEO means the other named executive officers (average). Total shareholder return is the value of a $100 investment.

  • 2025-12-31: PEO Gene G. Kinney; PEO total compensation $5.90M; PEO compensation actually paid $2.87M; Other NEO average total compensation $2.58M.
  • 2024-12-31: PEO Gene G. Kinney; PEO total compensation $7.23M; PEO compensation actually paid -$1.71M; Other NEO average total compensation $2.49M.
  • 2023-12-31: PEO Gene G. Kinney; PEO total compensation $7.04M; PEO compensation actually paid -$3.22M; Other NEO average total compensation $2.64M.
  • 2022-12-31: PEO Gene G. Kinney; PEO total compensation $6.74M; PEO compensation actually paid $7.40M; Other NEO average total compensation $2.70M.
Fiscal year endPEOPEO total compensationPEO compensation actually paidOther NEO average total compensationOther NEO average compensation actually paidTotal shareholder returnPeer group total shareholder returnNet incomeCompany-selected measureProxy filed
2025-12-31Gene G. Kinney$5.90M$2.87M$2.58M$1.86M$79.52$119.92-$244.09M2026-03-27
2024-12-31Gene G. Kinney$7.23M-$1.71M$2.49M-$204.49K$115.32$90.58-$122.31M2026-03-27
2023-12-31Gene G. Kinney$7.04M-$3.22M$2.64M-$1.23M$302.58$91.84-$147.03M2026-03-27
2022-12-31Gene G. Kinney$6.74M$7.40M$2.70M$4.10M$501.67$88.53-$116.95M2026-03-27
2021-12-31Gene G. Kinney$4.92M$41.14M$2.85M$12.63M$411.32$99.37$66.97M2026-03-27
2024-12-31Gene G. Kinney$7.23M-$1.71M$2.49M-$204.49K$87.49$113.84-$122.31M2025-03-28
2023-12-31Gene G. Kinney$7.04M-$3.22M$2.64M-$1.23M$229.56$115.42-$147.03M2025-03-28
2022-12-31Gene G. Kinney$6.74M$7.40M$2.70M$4.10M$380.61$111.27-$116.95M2025-03-28
2021-12-31Gene G. Kinney$4.92M$41.14M$2.85M$12.63M$312.07$124.89$66.97M2025-03-28
2020-12-31Gene G. Kinney$3.43M$62.29K$1.59M$866.85K$75.87$125.69-$111.14M2025-03-28
2023-12-31Gene G. Kinney$7.04M-$3.22M$2.64M-$1.23M$229.56$115.42-$147.03M2024-03-29
2022-12-31Gene G. Kinney$6.74M$7.40M$2.70M$4.10M$380.61$111.27-$116.95M2024-03-29
2021-12-31Gene G. Kinney$4.92M$41.14M$2.85M$12.63M$312.07$124.89$66.97M2024-03-29
2020-12-31Gene G. Kinney$3.43M$62.29K$1.59M$866.85K$75.87$125.69-$111.14M2024-03-29
2022-12-31Gene G. Kinney$6.74M$7.40M$2.70M$4.10M$380.61$111.27-$116.95M$0.002023-03-31
2021-12-31Gene G. Kinney$4.92M$41.14M$2.85M$12.63M$312.07$124.89$66.97M$0.002023-03-31
2020-12-31Gene G. Kinney$3.43M$62.29K$1.59M$866.85K$75.87$125.69-$111.14M$0.002023-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10